Latest news

• Almirall launches story campaign to raise rosacea awareness

  Almirall has launched a new story-based campaign to raise awareness of chronic dermatological disease rosacea in the US. ... After acquiring Poli Group in 2015, Almirall obtained a dermatology focused R&D structure including its rosacea brand.

• Golin Health wins HRA Pharma and Atlantis Healthcare accounts

  Golin Health opened its London office in 2013 and was a finalist in the excellence in digital communications category at last year's Comm uniqué Awards with its Rosacea Uncovered educational

• Bayer sues Glenmark over its skin disorder generic

  of mild to moderate rosacea – a chronic skin condition that mainly affects the face.

• Dermatology developments

  Launched. 268. Allergan/Vicept. Acquires Vicept dermatology development company with rosacea drug.

• Allergan acquires Vicept

  Vicept Therapeutics' lead investigational product is V-101, a topical cream for the treatment of the erythema associated with rosacea, which has achieved positive results in two randomised, placebo-controlled phase